Showing results (91-100 of 108) with videos related to

Sort By:
Pageof 11
Eclinicalmedicine|March 29, 2024
Prevalence of aggressive care among patients with cancer near the end of life: a systematic review and meta-analysisZhuo Ma, Huangqianyu Li, Yi Zhang, et al.
The Analyst|September 22, 2009
RRLC-MS/MS-based metabonomics combined with in-depth analysis of metabolic correlation network: finding potential biomarkers for breast cancerYanhua Chen, Ruiping Zhang, Yongmei Song, et al.
Clinical Therapeutics|November 30, 2024
Inappropriate Prescribing of Nirmatrelvir/Ritonavir in Solid Organ Transplantation With COVID-19 Infection: A Multicenter Retrospective StudyYing Zhang, Kuifen Ma, Wenjing Hou, et al.
BMJ Open Respiratory Research|December 4, 2025
Prevalence of potentially inappropriate use of antiviral therapy with simnotrelvir-ritonavir versus nirmatrelvir-ritonavir in hospitalised patients: a retrospective study in Beijing, ChinaYuezhen Zhu, Yi Zhang, Hui Yang, et al.
Journal of Proteome Research|June 22, 2010
Integrated ionization approach for RRLC-MS/MS-based metabonomics: finding potential biomarkers for lung cancerZhuoling An, Yanhua Chen, Ruiping Zhang, et al.
Clinical and Translational Science|September 17, 2024
Paired comparisons of venetoclax concentration in cerebrospinal fluid, bone marrow, and plasma in acute leukemia patientsYuan Jian, Feifei Han, Ying Zhu, et al.
Medicine|January 26, 2024
Comparison of clinical and economic evaluation between selected generic and original febuxostat tablets in Chinese gout patients with hyperuricemia: A real-world multicenter retrospective studyXia Si, Lin Huang, Qingming Ding, et al.
Cancer|April 28, 2026
Eligibility criteria for cancer drug trials in adult patients: Evidence from China, 2013-2021Zhuo Ma, Yichen Zhang, Dingyi Chen, et al.
Journal of Medical Virology|July 20, 2023
Oral azvudine for mild-to-moderate COVID-19 in high risk, nonhospitalized adults: Results of a real-world studyHui Yang, Zhaojian Wang, Chunguo Jiang, et al.
Antimicrobial Agents and Chemotherapy|January 30, 2024
Effectiveness and safety of nirmatrelvir-ritonavir in kidney transplant recipients with severe kidney dysfunction infected with COVID-19Hui Yang, Xin Yu, Wenjing Hou, et al.
Pageof 11